Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Study Results Show Promise for Osteoporosis Treatment

By Drug Discovery Trends Editor | March 23, 2016

An international study by The University of Western Australia may lead to a new treatment for osteoporosis caused by age-related bone loss in elderly women.

Osteoporosis is a common disease which makes bones become brittle and leads to a higher risk of breaks than in normal bone. It affects more than one million Australians and is known as the silent disease, because you rarely know you have it until you actually break a bone.

It occurs when bones lose minerals, such as calcium, more quickly than the body can replace them, causing a loss of bone thickness.

The new research, published in Nature Communications, found a new way that cells involved in bone structure were able to talk to each other.

Professor Jiake Xu from UWA’s School of Pathology and Laboratory Medicine said researchers focused on two types of cells, bone-resorbing osteoclasts which break down bone and bone-forming osteoblasts that regularly cross-talk within the body.

“Bone remodelling is regulated by these two types of cells that communicate with each other in several ways,” he said.

“One classic way that they do this is by making a protein, then secreting it and binding it to the receptor of another cell, or through cell-to-cell contact.”

Professor Xu said the new research found that osteoclasts could also produce, small  sac-like structures containing  MicroRNAs, or information, that could communicate with other cells.

“We’ve discovered the osteoclasts can send a message to osteoblasts about inhibiting bone growth, so if we could find a way to manipulate this to instead promote bone growth it could lead to new treatments for osteoporosis,” he said.

The research is the latest collaboration between Professor Xu and Professor Ge Zhang and Aiping Lu,from the Hong Kong Baptist University (HKBU).

Source: University of Western Australia 


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE